stockrow
Friday 6 November 2026
Export BKD’s income statement to Excel — free account
Brookdale Senior Living Inc.
BKD Healthcare Medical Care Facilities
Brookdale Senior Living Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 2.19% from fiscal 2024.
- Revenue
- −11.6%
- EPS
- +155.6%
- Free cash flow
- +533.1%
- Total debt
- +0.07%
Quarter to June 2026, against a year earlier
10.89
0.30
−2.68%
Follow BKD
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
1.26 | 1.04 | 0.79 | 0.62 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
41.86 | 155.95 | 73.47 | 26.29 | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
2.54 | 2.32 | 2.05 | 1.86 | |
EV/EBITDA |
17.75 | 18.77 | 17.05 | 16.03 | |
EV/Operating CF |
34.59 | 33.81 | 30.01 | 26.25 | |
EV/FCF |
(54.93) | (24.15) | (22.21) | (88.42) | |
Quick Ratio |
0.92 | 0.68 | 0.67 | 0.57 | |
Current Ratio |
1.14 | 1.03 | 0.98 | 0.84 | |
Net Debt/EBITDA |
24.45 | 31.31 | 38.71 | 89.31 | |
Debt/Assets |
73.19% | 73.44% | 72.52% | 71.31% | |
Debt/Equity |
(156.38) | (79.37) | (99.52) | (802.69) | |
Asset Turnover |
0.51 | 0.52 | 0.52 | 0.54 | |
Operating CF/Net income |
3.95 | (3.03) | (0.86) | (0.67) | |
Capex/Depreciation |
1.34 | (0.60) | (4.65) | (0.43) | |
Interest Coverage |
1.51 | 0.90 | 0.38 | (0.87) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
6.56% | 5.89% | 5.49% | 6.26% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.52% | 0.48% | 0.30% | 0.32% | |
Graham Net Nets |
(1.39) | (1.66) | (2.14) | (2.72) | |
Graham Number |
1.23 | 2.11 | 2.15 | 0.81 | |
Earnings Yield |
(3.60%) | (6.29%) | (10.29%) | (15.47%) | |
Free Cash Flow Yield |
(3.66%) | (9.26%) | (11.61%) | (3.38%) | |
Revenue per Share |
3.00 | 3.21 | 3.21 | 3.42 | |
Operating CF per Share |
0.38 | 0.09 | 0.15 | 0.32 | |
Capex per Share |
0.41 | (0.20) | (1.59) | (0.18) | |
Free Cash Flow per Share |
0.80 | (0.11) | (1.45) | 0.14 | |
Cash per Share |
1.77 | 1.27 | 1.33 | 1.24 | |
Shareholders Equity per Share |
(0.12) | (0.23) | (0.18) | (0.02) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(0.12) | (0.23) | (0.18) | (0.02) | |
Free Cash Flow |
190.86 | (25.59) | (340.14) | 33.89 | |
Working Capital |
74.61 | 17.98 | (13.98) | (100.83) | |
Capital Expenditures |
98.94 | (46.48) | (374.68) | (42.64) | |
Net Current Asset Value |
(5,332.33) | (5,399.83) | (5,441.68) | (5,481.11) | |
EV/EBIT |
73.02 | 204.13 | 484.68 | 0.00 | |
Capex to Sales |
(0.14) | 0.06 | 0.50 | 0.05 | |
Price to Operating Income |
36.29 | 91.25 | 188.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
56.25 | 61.13 | 59.79 | 60.28 | |
Average Payables |
83.45 | 78.75 | 70.31 | 79.02 | |
Average Assets |
6,021.64 | 6,051.75 | 6,143.90 | 5,975.92 | |
Average Common Equity |
39.58 | 46.78 | 85.26 | 144.49 |
Columns are period end dates